COLLEGE STATION, Texas / Sep 19, 2024 / Business Wire / Mays Business School at Texas A&M University and leading health and well-being company Humana Inc. have kicked off the 2024 Humana-Mays Healthcare Analytics Case Competition. The competition – in its eighth year – is a chance for students to showcase their analytical talents as they solve a real-world business problem. The prize package for the winning teams is $90,000, with $50,000 for first place, $20,000 for second place, $10,000 for third place and $5,000 each for fourth and fifth places.
Held virtually, the competition is open to all accredited educational institutions based in the United States. Full-time and part-time master’s students from AACSB accredited Master of Science, Master of Arts, Master of Information Systems, Master of Public Health, Master of Business Administration programs, or other similar master’s programs in business, healthcare, or analytics, are eligible to enter. Students are invited to create teams of two to four students from the same university to work through and develop a solution to a real-world business problem.
“We are proud to once again partner with Humana to provide the premier healthcare analytics case competition in the nation,” said Mays Business School Dean Nate Sharp. “This competition highlights the opportunity business leaders have to advance ideas, create solutions, and build a better future in healthcare. The vision for this competition aligns perfectly with our vision at Mays Business School: building a better future through business.”
“The evolution of technology in the healthcare industry has led to a dramatic shift in how we care for the populations we serve. By incorporating sophisticated data-driven strategies, we are able to improve quality and equity of care, resulting in better overall health outcomes,” said Humana Vice President of HQRI Technology and Analytics Scott Bagley, PhD. Bagley, a Texas A&M alumnus, who has served as a Case Competition Finalist Judge, added “This competition is important because it offers students from across the nation a creative space outside of the classroom in which they can contribute new perspectives and solutions to a real-world problem not found in textbooks, and this fosters growth and innovation.”
Teams are judged on the following criteria:
Key dates for 2024:
Top winners from previous years include Syracuse University (2023), UCLA (2022), Georgia Tech (2021); The Wharton School of the University of Pennsylvania (2020); University of California, Los Angeles (2018 & 2019); and Purdue University (2017).
See Official Rules and Guidelines for more information.
About Mays Business School
At Mays Business School, our vision is to build a better future through business. By providing leadership-centered, experiential education to more than 6,400 undergraduate, masters, and doctoral students in accounting, finance, management, management information systems, marketing, and supply chain management, Mays consistently ranks among the top public business schools for its programs and faculty research. Our mission is to develop leaders of character who make a positive difference in the communities where they live, work, and serve.
About Humana
Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.
Last Trade: | US$293.97 |
Daily Change: | 16.19 5.83 |
Daily Volume: | 2,221,854 |
Market Cap: | US$35.400B |
November 12, 2024 October 30, 2024 October 24, 2024 October 23, 2024 August 19, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB